Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Selumetinib, the first effective drug for advanced melanoma of the eye
Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA
Selumetinib, the first effective drug for advanced melanoma of the eye ( Dr Richard Carvajal - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Jun 2013
Extended use of tamoxifen reduces breast cancer recurrence and death
Prof Richard Gray - University of Oxford, Oxford, United Kingdom
Extended use of tamoxifen reduces breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, United Kingdom )
2 Jun 2013
Ipilimumab and BRAF inhibitors for advanced melanoma
Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013
Ten years of tamoxifen superior to five in reducing breast cancer recurrence...
Dr Richard G. Gray - University of Oxford, UK
Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death ( Dr Richard G. Gray - University of Oxford, UK )
2 Jun 2013
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )
2 Jun 2013
No survival benefit to adding bevacizumab to standard first-line chemoradiation...
Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA
No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma ( Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA )
2 Jun 2013
Bevacizumab extends survival for relapsed and advanced cervical cancer
Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center...
Bevacizumab extends survival for relapsed and advanced cervical cancer ( Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA )
2 Jun 2013
Comment on biennial visual inspection with acetic acid (VIA), or vinegar
Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA
Comment on biennial visual inspection with acetic acid (VIA), or vinegar ( Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA )
2 Jun 2013
Lapatinib in combination with chemotherapy in breast cancer
Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA
Lapatinib in combination with chemotherapy in breast cancer ( Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA )
2 Jun 2013
Cetuximab superior to bevacizumab for advanced colorectal cancer
Dr Volke Heinemann - University of Munich Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volke Heinemann - University of Munich Munich, Germany )
1 Jun 2013
Improving outcomes of childhood neuroblastoma
Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia...
Improving outcomes of childhood neuroblastoma ( Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA )
1 Jun 2013
Nivolumab produces long-lasting responses in patients with stage IV melanoma
Dr Mario Sznol - Yale Cancer Center, New Haven, USA
Nivolumab produces long-lasting responses in patients with stage IV melanoma ( Dr Mario Sznol - Yale Cancer Center, New Haven, USA )
1 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation